CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Nanjing Pharmaceutical Company Limited Company Snapshot
Nanjing Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nanjing Pharmaceutical Company Limited with three other companies in this sector in China: Sichuan Languang Development Co Ltd (2016 sales of 19.95 billion Chinese Renmimbi [US$2.95 billion] of which 102% was Real Estate Development & Management), Shanghai Fosun Pharmaceutical (Group) Company Limited (14.51 billion Chinese Renmimbi [US$2.14 billion] of which 70% was Pharmaceutical Manufacturing and R&D), and Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd (20.03 billion Chinese Renmimbi [US$2.96 billion] of which 39% was Health).

Sales Analysis. Nanjing Pharmaceutical Company Limited reported sales of 26.72 billion Chinese Renmimbi (US$3.95 billion) for the year ending December of 2016. This represents an increase of 7.7% versus 2015, when the company's sales were 24.81 billion Chinese Renmimbi. Sales at Nanjing Pharmaceutical Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 56%). Sales of Third-Part Logistics saw an increase that was more than double the company's growth rate: sales were up 81.4% in 2016, from 3.66 million Chinese Renmimbi to 6.64 million Chinese Renmimbi. Nanjing Pharmaceutical Company Limited also saw significant increases in sales in E-Business (up 71.4% to 93.24 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Nanjing Pharmaceutical Company Limited
  Stock Performance Chart for Nanjing Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 7.18
(Figures in Chinese Renmimbi)
1 Week -1.1%   13 Weeks 5.9%  
4 Weeks -7.5%   52 Weeks -19.8%  
 
Nanjing Pharmaceutical Company Limited Key Data:
  Ticker: 600713 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 26,718,947,589
(Year Ending Jan 2017).
Employees: 4,486
  Currency: Chinese Renmimbi Market Cap: 6,443,515,794
  Fiscal Yr Ends: December Shares Outstanding: 897,425,598
  Share Type: A Gu Closely Held Shares: 383,995,644
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.